Sensus Healthcare to Showcase Superficial Radiotherapy for Non-Invasive Skin Cancer Treatment at JPM Week 2026 in San Francisco
ByAinvest
Wednesday, Jan 7, 2026 4:32 pm ET1min read
SRTS--
Sensus Healthcare, a medical device company specializing in non-invasive treatments for skin conditions, will hold investor meetings during the JPM Week 2026 conference in San Francisco. The company's management will discuss recent developments, including a new coding system for superficial radiotherapy and a growing international presence. The conference is expected to be exciting and productive for Sensus in 2026.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet